Literature DB >> 31618556

Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease. Reply.

Oliver Distler1, Martina Gahlemann2, Toby M Maher3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31618556     DOI： 10.1056/NEJMc1910735

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

1.  Comparison of the effectiveness of cyclophosphamide and rituximab treatment in patients with systemic sclerosis-related interstitial lung diseases: a retrospective, observational cohort study.

Authors:  Deniz Demir Yılmaz; Sermin Borekci; Benan Musellim
Journal:  Clin Rheumatol       Date:  2021-05-31       Impact factor: 2.980

Review 2.  A Narrative Review of Pathogenetic and Histopathologic Aspects, Epidemiology, Classification Systems, and Disease Outcome Measures in Systemic Sclerosis.

Authors:  Maria-Grazia Lazzaroni; Silvia Piantoni; Fabrizio Angeli; Stefania Bertocchi; Franco Franceschini; Paolo Airò
Journal:  Clin Rev Allergy Immunol       Date:  2022-03-07       Impact factor: 10.817

3.  Safety and efficacy of abatacept in patients with treatment-resistant SARCoidosis (ABASARC) - protocol for a multi-center, single-arm phase IIa trial.

Authors:  Björn C Frye; Ina Caroline Rump; Annette Uhlmann; Fabian Schubach; Gabriele Ihorst; Bodo Grimbacher; Gernot Zissel; Joachim Müller Quernheim
Journal:  Contemp Clin Trials Commun       Date:  2020-05-29

Review 4.  Estimation of the Prevalence of Progressive Fibrosing Interstitial Lung Diseases: Systematic Literature Review and Data from a Physician Survey.

Authors:  Amy Olson; Nadine Hartmann; Padmaja Patnaik; Laura Wallace; Rozsa Schlenker-Herceg; Mouhamad Nasser; Luca Richeldi; Anna-Maria Hoffmann-Vold; Vincent Cottin
Journal:  Adv Ther       Date:  2020-12-14       Impact factor: 3.845

5.  Successful treatment of severe interstitial pneumonia by removal of circulating autoantibodies: a case series.

Authors:  Philipp Eller; Holger Flick; Gernot Schilcher; Florentine Moazedi-Fürst; Kathrin Eller; Emina Talakic; Josef Hermann; Yannick Allanore; Horst Olschewski
Journal:  BMC Pulm Med       Date:  2021-01-06       Impact factor: 3.317

Review 6.  PDGF/PDGFR: A Possible Molecular Target in Scleroderma Fibrosis.

Authors:  Chiara Paolini; Silvia Agarbati; Devis Benfaremo; Matteo Mozzicafreddo; Silvia Svegliati; Gianluca Moroncini
Journal:  Int J Mol Sci       Date:  2022-03-31       Impact factor: 5.923

Review 7.  Classifying the Linkage between Adipose Tissue Inflammation and Tumor Growth through Cancer-Associated Adipocytes.

Authors:  Yae Chan Song; Seung Eon Lee; Young Jin; Hyun Woo Park; Kyung-Hee Chun; Han-Woong Lee
Journal:  Mol Cells       Date:  2020-09-30       Impact factor: 5.034
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.